zarelis
italfarmaco s.p.a. - venlafaxina - venlafaxina
degarelix accord
accord healthcare s.l.u. - degarelix acetate - neoplasie prostatiche - other hormone antagonists and related agents - degarelix accord is a gonadotrophin releasing hormone (gnrh) antagonist indicated:for treatment of adult male patients with advanced hormone-dependent prostate cancer. for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.
ganirelix labatec 0,25 mg soluzione iniettabile en seringue préremplie
labatec pharma sa - ganirelixum - soluzione iniettabile en seringue préremplie - ganirelixum 0.25 mg ut ganirelixi acetas, acidum aceticum glaciale, mannitolum, natrii hydroxidum q.s. ad ph, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 0.023 mg. - médecine de reproduction assistée - biotechnologika
ganirelix gedeon richter
chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - ormoni ipofisari e ipotalamici e analoghi - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).
fyremadel
sun pharmaceutical industries (europe) b.v. - ganirelix - ganirelix
orgalutran soluzione iniettabile
organon gmbh - ganirelixum - soluzione iniettabile - ganirelixum 0.25 mg ut ganirelixi acetas, mannitolum, acidum aceticum glaciale, natrii hydroxidum aut acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp., natrium 0.21 mg. - medicina della riproduzione assistita - biotechnologika
ceziboe
sun pharmaceutical industries (europe) b.v. - cetrorelix - cetrorelix
ovamex
theramex ireland limited - ganirelix - ganirelix
cetrotide
merck europe b.v. - cetrorelix (as acetate) - ovulation; ovulation induction - ormoni ipofisari e ipotalamici e analoghi - prevenzione dell'ovulazione prematura in pazienti sottoposti a stimolazione ovarica controllata, seguita da tecniche di prelievo ovocitario e di riproduzione assistita. negli studi clinici, il cetrotide è stato utilizzato con gonadotropina umana della menopausa (hmg), tuttavia, limitata esperienza con ricombinante follicule-ormone stimolante (fsh) ha suggerito l'efficacia simile.
firmagon
ferring pharmaceuticals a/s - degarelix - neoplasie prostatiche - terapia endocrina - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.